Who is sponsoring NCT07397741?

NCT07397741 is sponsored by Sohag University.

What drugs are being tested in NCT07397741?

Interventions in NCT07397741: Gene expression by quantitative Real Time PCR.

What condition does NCT07397741 study?

NCT07397741 studies Rhematoid Arthritis.

Is NCT07397741 still recruiting?

NCT07397741 is currently not yet recruiting. Last updated 9 February 2026.

Last reviewed 2026-02-09 · How we verify

NCT07397741

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluation of CCR6 Gene Expression and Circulating CCL20 Levels as Potential Biomarkers in Rheumatoid Arthritis

Not yet recruiting Last updated 9 February 2026

What this trial tests

trial testing Gene expression by quantitative Real Time PCR in Rhematoid Arthritis in 60 participants. Not yet recruiting.

Timeline

1 March 2026

Primary endpoint
1 February 2027

1 March 2027

Quick facts

Lead sponsor	Sohag University
Status	Not yet recruiting
Study type	OBSERVATIONAL
Enrollment	60
Start date	1 March 2026
Primary completion	1 February 2027
Estimated completion	1 March 2027

Drugs / interventions tested

Gene expression by quantitative Real Time PCR

Conditions studied

Rhematoid Arthritis — all drugs for Rhematoid Arthritis →

Sponsor

Sohag University

Who can join

Adults 18 to 60, any sex, with Rhematoid Arthritis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Rheumatoid arthritis (RA) is characterized as a systemic auto immune disorder linked to a persistent inflammatory process that can harm both joints and extra articular organs. The upregulation of the CCR6/CCL20 axis in the synovial tissues and salivary glands (in cases of secondary Sjögren's syndrome) is considered to contribute to the recruitment of Th17 cells, which in turn enhances IL 17A production and promotes the inflammatory cycle.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Rhematoid Arthritis

Currently open trials in the same condition.

NCT07375082 — Rehabilitation Approaches Used in Total Knee Replacement · active not recruiting
NCT07388407 — Pharmacogenetics of Leflunomide in the Management of Rheumatoid Arthritis · recruiting

Other Sohag University trials

Trials by the same sponsor.

NCT07119905 — Association Between Matrix Metalloproteinase-9 Gene Polymorphism and Susceptibility to Primary Open Angle Glaucoma Patie · not yet recruiting
NCT07512219 — Comparison Between Greater Occipital Nerve Block and Pulsed Radiofrequency in the Management of Chronic Migraine · NA · not yet recruiting
NCT07519694 — Comparative Study Between Different Additives to Lidocaine 2٪ for Peribulbar Block in Vitreoretinal Surgery · NA · not yet recruiting
NCT07515365 — Colitis Patterns in Patients With Lower GI Symptoms · not yet recruiting
NCT07523386 — Compartive Study Between Cannulated Screw and Kws in Fixation of Distal Radius · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07397741 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Sohag University
Last refreshed: 9 February 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07397741.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing